Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

BUY
$85.37 - $115.44 $10,415 - $14,083
122 Added 5.97%
2,164 $230,000
Q1 2023

Apr 20, 2023

BUY
$135.66 - $197.02 $6,783 - $9,851
50 Added 2.51%
2,042 $313,000
Q4 2022

Jan 27, 2023

BUY
$118.38 - $210.04 $35,514 - $63,012
300 Added 17.73%
1,992 $0
Q2 2022

Aug 09, 2022

BUY
$117.13 - $176.59 $198,183 - $298,790
1,692 New
1,692 $278,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Mayfair Advisory Group, LLC Portfolio

Follow Mayfair Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mayfair Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mayfair Advisory Group, LLC with notifications on news.